MIA
ZBH icon

MainStreet Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

MainStreet Investment Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,458
Closed -$588K – 184
2024
Q1 		$588K Sell
4,458
-506
-10% -$63.2K 0.07% 118
2023
Q4 		$604K Buy
4,964
+214
+5% +$23.9K 0.07% 116
2023
Q3 		$533K Sell
4,750
-199
-4% -$25.3K 0.06% 126
2023
Q2 		$721K Buy
4,949
+42
+0.9% +$5.71K 0.08% 111
2023
Q1 		$634K Sell
4,907
-292
-6% -$36.7K 0.07% 123
2022
Q4 		$663K Buy
+5,199
New +$603K 0.07% 115
2022
Q3 		– Sell
-4,906
Closed -$515K – 172
2022
Q2 		$515K Buy
4,906
+249
+5% +$29.5K 0.06% 125
2022
Q1 		$596K Sell
4,657
-134
-3% -$16.2K 0.06% 131
2021
Q4 		$591K Sell
4,791
-190
-4% -$24.9K 0.05% 132
2021
Q3 		$707K Buy
4,981
+45
+0.9% +$6.62K 0.07% 112
2021
Q2 		$770K Buy
4,936
+62
+1% +$10K 0.07% 115
2021
Q1 		$757K Sell
4,874
-59
-1% -$9.14K 0.06% 115
2020
Q4 		$738K Sell
4,933
-204
-4% -$28.8K 0.06% 113
2020
Q3 		$679K Sell
5,137
-94
-2% -$12.3K 0.05% 115
2020
Q2 		$606K Sell
5,231
-1,198
-19% -$138K 0.04% 161
2020
Q1 		$631K Buy
6,429
+1,509
+31% +$198K 0.08% 135
2019
Q4 		$715K Buy
4,920
+187
+4% +$25.8K 0.08% 111
2019
Q3 		$630K Sell
4,733
-3
-0.1% -$388 0.08% 105
2019
Q2 		$541K Buy
+4,736
New +$555K 0.07% 113
2019
Q1 		– Sell
-4,970
Closed -$500K – 166
2018
Q4 		$500K Sell
4,970
-70
-1% -$7.87K 0.08% 104
2018
Q3 		$643K Buy
5,040
+13
+0.3% +$1.55K 0.09% 107
2018
Q2 		$544K Buy
5,027
+411
+9% +$44.7K 0.08% 106
2018
Q1 		$489K Sell
4,616
-158
-3% -$18.3K 0.08% 108
2017
Q4 		$559K Buy
+4,774
New +$540K 0.09% 109

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MainStreet Investment Advisors's ZBH Position: Q2 2024 in Review

MainStreet Investment Advisors sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 4,458 shares — an estimated $588K sold.

MainStreet Investment Advisors first reported a position in ZBH in Q4 2017 and held it in 24 quarters. The position peaked at $770K in Q2 2021. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • MainStreet Investment Advisors reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • MainStreet Investment Advisors sold 4,458 Zimmer Biomet shares in Q2 2024, an estimated $588K.
  • MainStreet Investment Advisors first reported a position in Zimmer Biomet in Q4 2017 and held it in 24 quarters.
  • MainStreet Investment Advisors's Zimmer Biomet position peaked at $770K in Q2 2021.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on MainStreet Investment Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.